Macquarie Group
VBIV

Macquarie Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Macquarie Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-564
Closed -$13K – 2447
2022
Q3 		$13K Sell
564
-71
-11% -$1.91K ﹤0.01% 2320
2022
Q2 		$15K Hold
635
– – ﹤0.01% 2384
2022
Q1 		$32 Hold
635
– – ﹤0.01% 2283
2021
Q4 		$45K Sell
635
-265
-29% -$22.3K ﹤0.01% 2190
2021
Q3 		$84K Buy
900
+564
+168% +$53.6K ﹤0.01% 2038
2021
Q2 		$34K Sell
336
-45
-12% -$4.39K ﹤0.01% 2243
2021
Q1 		$36K Buy
+381
New +$38.6K ﹤0.01% 2152
2018
Q1 		– Sell
-70
Closed -$9K – 2412
2017
Q4 		$9K Buy
+70
New +$8.61K ﹤0.01% 2287

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return